Manufacturer record
Plena Remedies: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
9 batches manufactured by Plena Remedies (Himachal Pradesh) were declared Not of Standard Quality between July 2022 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: PGC25-377E, Rabeprazole Sodium (EC) & Domperidone (SR) Capsules (exp Oct 2027). GORAKHPUR LAB (state lab) found it not of standard quality: The sample does not conform to declared formula in respect of content of Rabeprazole Sodium. Listed in the August 2026 alert.
Records by type
9 records linked to Plena Remedies in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rabeprazole Sodium (EC) & Domperidone (SR) Capsules | Batch PGC25-377EMfg Nov 2025 · Exp Oct 2027 | The sample does not conform to declared formula in respect of content of Rabeprazole SodiumOther | GORAKHPUR LABState lab | Aug 2026 |
| Atorvastatin and Clopidogrel Tablets | Batch PGT25-3110AMfg Nov 2025 · Exp Oct 2027 | Does not conform to required standards with respect to the test AssayAssay | Food & Drugs Laboratory Bambolim, GoaState lab | Jul 2026 |
| Levocetirizine Tablets IP | Batch PGT25-2392GMfg Sep 2025 · Exp Aug 2027 | The sample does not conforms to the IP with respect to Assay of Levocetirizine Hydrochloride.Assay | DTL JaipurState lab | May 2026 |
| Esomeprazole (EC) & Itopride Hydrochloride Capsule | Batch PGC25-08Mfg Mar 2025 · Exp Feb 2027 | The sample does not conforms to the claim with respect to Assay of EsomeprazoleAssay | DTL, UdaipurState lab | Dec 2025 |
| Clarithromycin Oral Suspension USP | Batch PGD4075AMfg Dec 2024 · Exp Nov 2026 | Test for pH and Assay for ClarithromycinAssay | DTL, Bengaluru, KarnatakaState lab | Nov 2025 |
| Sodonate-500 (Sodium Bicarbonate Tablets USP 500 mg) | Batch PNT5806Mfg Dec 2021 · Exp Nov 2023 | Assay and Uniformity of dosage unitsAssay | CDTL MumbaiCDSCO lab | Aug 2022 |
| Iverzest 12 (Ivermectin Dispersible Tablets 12 mg) | Batch PNT3940DMfg May 2021 · Exp Apr 2023 | Uniformity of DispersionUniformity of weight/content | CDL KolkataCDSCO lab | Aug 2022 |
| Rabeprazole Gastro-Resistant Tablets IP (Wrabzole-20) | Batch PNT2435BMfg Sep 2020 · Exp Aug 2022 | Assay & Related SubstancesAssay | RDTL GuwahatiState lab | Jul 2022 |
| Rabeprazole Gastro-Resistant Tablets IP | Batch PNT2435BMfg Sep 2020 · Exp Aug 2022 | Assay & DescriptionAssay | RDTL GuwahatiState lab | Jul 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.